Capsid-engineering overcomes barriers toward endothelial cell transduction:
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Abschlussarbeit Buch |
Sprache: | English |
Veröffentlicht: |
Köln
2015
|
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis Inhaltsverzeichnis |
Beschreibung: | V, 98 Seiten Illustrationen, Diagramme 21 cm |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV043858849 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | t | ||
008 | 161103s2015 gw a||| m||| 00||| eng d | ||
015 | |a 16,H10 |2 dnb | ||
016 | 7 | |a 1110917694 |2 DE-101 | |
035 | |a (OCoLC)965508724 | ||
035 | |a (DE-599)DNB1110917694 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
044 | |a gw |c XA-DE-NW | ||
049 | |a DE-355 |a DE-83 | ||
082 | 0 | |a 572.6963329247 |2 22/ger | |
084 | |a 610 |2 sdnb | ||
084 | |a 570 |2 sdnb | ||
100 | 1 | |a Zhang, Li-Ang |d 1982- |e Verfasser |0 (DE-588)1106258037 |4 aut | |
245 | 1 | 0 | |a Capsid-engineering overcomes barriers toward endothelial cell transduction |c vorgelegt von Li-Ang Zhang |
264 | 1 | |a Köln |c 2015 | |
300 | |a V, 98 Seiten |b Illustrationen, Diagramme |c 21 cm | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
502 | |b Dissertation |c Universität zu Köln |d 2016 | ||
655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
856 | 4 | 2 | |m B:DE-101 |q application/pdf |u http://d-nb.info/1110917694/04 |3 Inhaltsverzeichnis |
856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=029269003&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-029269003 |
Datensatz im Suchindex
_version_ | 1804176737636974592 |
---|---|
adam_text | Titel: Capsid-engineering overcomes barriers toward endothelial cell transduction
Autor: Zhang, Li-Ang
Jahr: 2015
Table of contents
SUMMARY....................................1
ZUSAMMENFASSUNG.............................2
INTRODUCTION........................................................................................................3
2.1 Chemicals, solutions and enzymes....................................................................19
2.2 Reagent setup.....................................................................................................20
2.3 Standard kits......................................................................................................21
2.4 Plasmids..............................................................................................................22
2.5 Primers................................................................................................................23
2.6 Single-stranded oligonucleotides...................................................................24
2.7 Antibodies............................................................................................................24
2.8 Bacteria strain...................................................................................................25
2.9 Eukaryotic cells...............................................................................................25
2 10 Equipments and disposables..............................................................................25
2 11 Data treating son ware.....................................................................................26
3 METHODS...............................................................................................................27
3.1 Bacteria...............................................................................................................27
3.1.1 Cultivation of bacteria...................................................................................................27
3.1.2 Preparation of chemically competent bacteria.........................................................27
3.1.3 Transformation of bacteria...........................................................................................27
3.1.4 DNA expansion in bacteria..........................................................................................28
3.2 Modification, purification and quantification of nucleic acid........................28
3.2.1 Oligonucleotide hybridization......................................................................................28
3.2.2 Production ofpLG construct........................................................................................28
3.2.3 Production of pLG backbone.......................................................................................29
3.2.4 Production of AA V sub-library plasmid pool.............................................................29
3.2.5 DNA purification by gel electrophoresis....................................................................30
3.2.6 DNA extraction from cells............................................................................................31
3.2.7 RNA extraction from cells............................................................................................31
3.2.8 Measurement of nucleic acid concentration.............................................................31
3.3 Polymerase Chain Reaction (PGR)....................................................................31
3.3.1 PCR for cloning.............................................................................................................31
3.3.2 PCR for Sanger sequencing........................................................................................33
3.3.3 Real-time PCR (qPCR)................................................................................................34
3.3.4 Reverse transcriptase PCR (RT-PCRj......................................................................36
3.4 NEXT GENERATION SEQUENCING.............................................................................37
3.4.1 Preparation of amplicon...............................................................................................37
3.4.2 Emulsion PCR...............................................................................................................37
3.4.3 454-pyrosequencing and analysis of sequences.....................................................37
3.5 Protein................................................................................................................37
3.5.1 Acetone precipitation of protein fractions..................................................................37
3.5.2 Western Blot..................................................................................................................38
3.6 Eukaryotic cell culture....................................................................................39
3.6.1 Cultivation of cells.........................................................................................................35
3.6.2 Trypsin and accutase treatment.................................................................................40
3.6.3 Counting, seeding and passaging..............................................................................40
3.6.4 Freezing and thawing cells..........................................................................................40
3.6.5 Cell fractionation...........................................................................................................40
3.6.6 Induction of quiescent HUVEC.......................................................41
3.7 AAV library.........................................................................................................41
3.7.1 AAV library production and purification.....................................................................41
3.7.1.1 AAV library packaging.............................................................................................41
3.7.1.2 lodixanol gradient purification................................................................................42
3.7.1.3 Vector titration........................................................................................................42
3.7.1.4 Coupling of pheno- and geno-type of mutants.......................................................43
3.7.2 AAV library screening...................................................................................................43
3.8 Cell transduction assay by capsid-modified MV vectors..............................44
3.8.1 AAV vector production.................................................................................................44
3.8.2 Transduction of HUVEC by capsid-modified AAV vectors.....................................45
3.8.3 Cell transduction assay................................................................................................45
3.8.3.1 Flow cytometry........................................................................................................45
3.8.3.2 Benzonase protection assay....................................................................................46
3.8.3.3 Quantification of vector entry efficiency.................................................................46
3.9 Statistical analysis............................................................................................46
4 RESULTS.................................................................................................................47
4.1 Selection of EC variants...................................................................................47
4.1.1 Characterization of cell surface receptors.................................................................47
4.1.2 Using the targeting technology to understand barriers of EC transduction.........49
4.1.3 Selection criteria............................................................................................................49
4.1.4 Selection procedure......................................................................................................49
4.2 Characterization of selected variants............................................................56
4.2.1 AAV capsid-modified vectors transduce HUVEC with higher efficiency..............56
4.2.2 AAV capsid-modified vectors enter cells more efficient thanAAV2......................57
4.2.3 AAV capsid-modified vectors outperform AAV2 in number of particles that
accumate in the perinuclear area...............................................................................58
4.2.4 AAV capsid-modified vectors differ in the onset of transgene expression...........59
4.2.5 The benzonase protection assay does not reveal any difference in uncoating
efficiency........................................................................................................................60
4.2.6 Single-strand conversion is a post-entry barrier that hampers EC transduction. 61
4.2.7 AAV-V is inhibited by heparin like AA V2 in EC transduction.................................62
4.2.8 Empty capsid of AA V-V and AA V2 do not enter the nuclear area........................63
4.2.9 AAV-V is superior to the variants identified in previous studies in EC
transduction...................................................................................................................63
4.3 Characterization of selected variants in preliminary study for in vivo
TESTS....................................................................................................................64
5 DISCUSSION.............................................................................................................
5.1 AAVLIBRARY SCREENING WITH NGS.......................................................................69
5.2 Cell receptor interaction.................................................................................71
5.3 Cell entry barriers............................................................................................73
5.4 Summary and perspec tivesofAAV- V s applica tion..........................................75
6 REFERENCE...................................................77
S ERKLARUNG.......................................................98
|
any_adam_object | 1 |
author | Zhang, Li-Ang 1982- |
author_GND | (DE-588)1106258037 |
author_facet | Zhang, Li-Ang 1982- |
author_role | aut |
author_sort | Zhang, Li-Ang 1982- |
author_variant | l a z laz |
building | Verbundindex |
bvnumber | BV043858849 |
ctrlnum | (OCoLC)965508724 (DE-599)DNB1110917694 |
dewey-full | 572.6963329247 |
dewey-hundreds | 500 - Natural sciences and mathematics |
dewey-ones | 572 - Biochemistry |
dewey-raw | 572.6963329247 |
dewey-search | 572.6963329247 |
dewey-sort | 3572.6963329247 |
dewey-tens | 570 - Biology |
discipline | Biologie Medizin |
format | Thesis Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01391nam a2200361 c 4500</leader><controlfield tag="001">BV043858849</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">161103s2015 gw a||| m||| 00||| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">16,H10</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1110917694</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)965508724</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1110917694</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-NW</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-83</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">572.6963329247</subfield><subfield code="2">22/ger</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">570</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Zhang, Li-Ang</subfield><subfield code="d">1982-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1106258037</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Capsid-engineering overcomes barriers toward endothelial cell transduction</subfield><subfield code="c">vorgelegt von Li-Ang Zhang</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Köln</subfield><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">V, 98 Seiten</subfield><subfield code="b">Illustrationen, Diagramme</subfield><subfield code="c">21 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="b">Dissertation</subfield><subfield code="c">Universität zu Köln</subfield><subfield code="d">2016</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">B:DE-101</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://d-nb.info/1110917694/04</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=029269003&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029269003</subfield></datafield></record></collection> |
genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
genre_facet | Hochschulschrift |
id | DE-604.BV043858849 |
illustrated | Illustrated |
indexdate | 2024-07-10T07:36:56Z |
institution | BVB |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029269003 |
oclc_num | 965508724 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR DE-83 |
owner_facet | DE-355 DE-BY-UBR DE-83 |
physical | V, 98 Seiten Illustrationen, Diagramme 21 cm |
publishDate | 2015 |
publishDateSearch | 2015 |
publishDateSort | 2015 |
record_format | marc |
spelling | Zhang, Li-Ang 1982- Verfasser (DE-588)1106258037 aut Capsid-engineering overcomes barriers toward endothelial cell transduction vorgelegt von Li-Ang Zhang Köln 2015 V, 98 Seiten Illustrationen, Diagramme 21 cm txt rdacontent n rdamedia nc rdacarrier Dissertation Universität zu Köln 2016 (DE-588)4113937-9 Hochschulschrift gnd-content B:DE-101 application/pdf http://d-nb.info/1110917694/04 Inhaltsverzeichnis HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=029269003&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Zhang, Li-Ang 1982- Capsid-engineering overcomes barriers toward endothelial cell transduction |
subject_GND | (DE-588)4113937-9 |
title | Capsid-engineering overcomes barriers toward endothelial cell transduction |
title_auth | Capsid-engineering overcomes barriers toward endothelial cell transduction |
title_exact_search | Capsid-engineering overcomes barriers toward endothelial cell transduction |
title_full | Capsid-engineering overcomes barriers toward endothelial cell transduction vorgelegt von Li-Ang Zhang |
title_fullStr | Capsid-engineering overcomes barriers toward endothelial cell transduction vorgelegt von Li-Ang Zhang |
title_full_unstemmed | Capsid-engineering overcomes barriers toward endothelial cell transduction vorgelegt von Li-Ang Zhang |
title_short | Capsid-engineering overcomes barriers toward endothelial cell transduction |
title_sort | capsid engineering overcomes barriers toward endothelial cell transduction |
topic_facet | Hochschulschrift |
url | http://d-nb.info/1110917694/04 http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=029269003&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
work_keys_str_mv | AT zhangliang capsidengineeringovercomesbarrierstowardendothelialcelltransduction |
Es ist kein Print-Exemplar vorhanden.
Inhaltsverzeichnis